RJF vs SNOA · rev $15.91B vs rev $19.5M
RJF (RJF) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
RJF (RJF) common stock.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
RJF currently screens at market cap $0. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the RJF and SNOA stock pages for the full models.
Not investment advice.